NCT00002346View on ClinicalTrials.gov

The Safety and Effectiveness of Bis-POM PMEA in HIV-Infected Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Adefovir dipivoxil

Trial Locations (1)

21205

Johns Hopkins Univ, Baltimore

Sponsors

Lead Sponsor

Gilead Sciences
All Listed Sponsors
lead

Gilead Sciences

INDUSTRY

NCT00002346 - The Safety and Effectiveness of Bis-POM PMEA in HIV-Infected Patients | Biotech Hunter | Biotech Hunter